Double focus in the modelling of anti-influenza properties of 2-iminobenzimidazolines: pharmacology and toxicology

References

• World Health Organization, Influenza (Seasonal), 6 November 2018, Retrieved 22 June 2021. Available at https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).
   Google Scholar
• A.C. Hurt, M.G. Ison, F.G. Hayden, and A.J. Hay, Second isirv antiviral group conference: Overview, Influenza Other Respir. Viruses 7 (2013), pp. 1–7. doi:10.1111/irv.12207.
   PubMed Web of Science ®Google Scholar
• Y. Furuse, A. Suzuki, and H. Oshitani, Large-scale sequence analysis of M gene of influenza A viruses from different species: Mechanisms for emergence and spread of amantadine resistance, Antimicrob. Agents Chemother. 53 (2009), pp. 4457–4463. doi:10.1128/AAC.00650-09.
   PubMed Web of Science ®Google Scholar
• Y. Abed, N. Goyette, and G. Boivin, Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations, Antimicrob. Agents Chemother. 49 (2005), pp. 556–559. doi:10.1128/AAC.49.2.556-559.2005.
   PubMed Web of Science ®Google Scholar
• M. Samson, A. Pizzorno, Y. Abed, and G. Boivin, Influenza virus resistance to neuraminidase inhibitors, Antiviral Res. 98 (2013), pp. 174–185. doi:10.1016/j.antiviral.2013.03.014.
   PubMed Web of Science ®Google Scholar
• R.S. Keri, A. Hiremathad, S. Budagumpi, and B.M. Nagaraja, Comprehensive review in current developments of benzimidazole-based medicinal chemistry, Chem. Biol. Drug Des. 86 (2015), pp. 19–65.
   PubMed Web of Science ®Google Scholar
• R. Sivakumar, R. Pradeepchandran, K.N. Jayaveera, P. Kumarnallasivan, P.R. Vijaianand, and R. Venkatnarayanan, Benzimidazole: An attractive pharmacophore in medicinal chemistry, Int. J. Pharm. Res. 3 (2011), pp. 19–31.
   Google Scholar
• Y. Bansal and O. Silakari, The therapeutic journey of benzimidazoles: A review, Bioorg. Med. Chem. 20 (2012), pp. 6208–6236. doi:10.1016/j.bmc.2012.09.013.
   PubMed Web of Science ®Google Scholar
• K.P. Barot, S. Nikolova, I. Ivanov, and M.D. Ghate, Novel research strategies of benzimidazole derivatives: A review, Mini-Rev. Med. Chem. 13 (2013), pp. 1421–1447. doi:10.2174/13895575113139990072.
   PubMed Web of Science ®Google Scholar
• K.-L. Yu, X.A. Wang, R.L. Civiello, A.K. Trehan, B.C. Pearce, Z. Yin, K.D. Combrink, H.B. Gulgeze, Y. Zhang, K.F. Kadow, C.W. Cianci, J. Clarke, E.V. Genovesi, I. Medina, L. Lambo, P.R. Wyde, M. Krystal, and N.A. Meanwell, Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo, Bioorg. Med. Chem. Lett. 16 (2006), pp. 1115–1122. doi:10.1016/j.bmcl.2005.11.109.
   PubMedGoogle Scholar
• P.S. Seth, E.A. Jefferson, R.H. Griffey, and E.E. Swayze, Benzimidazoles and analogs thereof as antivirals, US Pat. 8,207,173 B2 (2012).
   Google Scholar
• V.V. Zarubaev, A.S. Morkovnik, L.N. Divaeva, L.A. Karpinskaya, and G.S. Borodkin, Tautomeric and non-tautomeric N-substituted 2-iminobenzimidazolines as new lead compounds for the design of anti-influenza drugs: An in vitro study, Bioorg. Med. Chem. 24 (2016), pp. 5796–5803. doi:10.1016/j.bmc.2016.09.036.
   PubMed Web of Science ®Google Scholar
• R. Veerasamy and H. Rajak, QSAR studies on neuraminidase inhibitors as anti-influenza agents, Turk. J. Pharm. Sci. 18 (2021), pp. 151–156. doi:10.4274/tjps.galenos.2020.45556.
   PubMed Web of Science ®Google Scholar
• S.J. Barigye and M.P. Freitas, Ten years of the MIA-QSAR strategy: Historical development and applications, Int. J. Quant. Struct. Prop. Relat. 1 (2016), pp. 64–77.
   Google Scholar
• S.J. Barigye, M.H. Duarte, C.A. Nunes, and M.P. Freitas, MIA-plot: A graphical tool for viewing descriptor contributions in MIA-QSAR, RSC Adv. 6 (2016), pp. 49604–49612. doi:10.1039/C6RA09593C.
   Web of Science ®Google Scholar
• C.N. Borges, S.J. Barigye, and M.P. Freitas, Towards molecular design using 2D-molecular contour maps obtained from PLS regression coefficients, Mol. Phys. 115 (2017), pp. 3044–3050. doi:10.1080/00268976.2017.1347294.
   Web of Science ®Google Scholar
• K. Roy, S. Kar, and P. Ambure, On a simple approach for determining applicability domain of QSAR models, Chemom. Intell. Lab. Sys. 145 (2015), pp. 22–29. doi:10.1016/j.chemolab.2015.04.013.
   Web of Science ®Google Scholar
• I. Mitra, A. Saha, and K. Roy, Exploring quantitative structure–activity relationship studies of antioxidant phenolic compounds obtained from traditional Chinese medicinal plants, Mol. Simul. 36 (2010), pp. 1067–1079. doi:10.1080/08927022.2010.503326.
   Web of Science ®Google Scholar
• V. Consonni, D. Ballabio, and R. Todeschini, Comments on de definition of the Q2 parameter for QSAR validation, J. Chem. Inf. Model. 49 (2009), pp. 1669–1678. doi:10.1021/ci900115y.
   PubMed Web of Science ®Google Scholar
• R. Kiralj and M.C. Ferreira, Basic validation procedures for regression models in QSAR and QSPR studies: Theory and application, J. Braz. Chem. Soc. 20 (2009), pp. 770–787. doi:10.1590/S0103-50532009000400021.
   Web of Science ®Google Scholar
• A. Golbraikh and A. Tropsha, Beware of q2!, J. Mol. Graph. Modell. 20 (2002), pp. 269–276. doi:10.1016/S1093-3263(01)00123-1.
   PubMed Web of Science ®Google Scholar
• K. Roy, P. Chakraborty, I. Mitra, P.K. Ojha, S. Kar, and R.N. Das, Some case studies on application of “rm2” metrics for judging quality of quantitative structure-activity relationship predictions: Emphasis on scaling of response data, J. Comput. Chem. 34 (2013), pp. 1071–1082. doi:10.1002/jcc.23231.
   PubMed Web of Science ®Google Scholar
• K. Roy, I. Mitra, S. Kar, P.K. Ojha, R.N. Das, and H. Kabir, Comparative studies on some metrics for external validation of QSPR models, J. Chem. Inf. Model. 52 (2012), pp. 396–408. doi:10.1021/ci200520g.
   PubMed Web of Science ®Google Scholar
• N. Chirico and P. Gramatica, Real external predictivity of QSAR models: How to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient, J. Chem. Inf. Model. 51 (2011), pp. 2320–2335. doi:10.1021/ci200211n.
   PubMed Web of Science ®Google Scholar
• N. Chirico and P. Gramatica, Real external predictivity of QSAR models. Part 2. New intercomparable thresholds for different validation criteria and the need for scatter plot inspection, J. Chem. Inf. Model. 52 (2012), pp. 2044–2058. doi:10.1021/ci300084j.
   PubMed Web of Science ®Google Scholar
• R.D. Dennington, T.A. Keith, and M.J. Millam, GaussView 5.0, Semichem Inc., Shawnee Mission, Wallingford, CT, 2008.
   Google Scholar
• A. Tropsha, Best practices for QSAR model development, validation, and exploitation, Mol. Inf. 29 (2010), pp. 476–488. doi:10.1002/minf.201000061.
   PubMed Web of Science ®Google Scholar
• C.A. Nunes, M.P. Freitas, A.C.M. Pinheiro, and S.C. Bastos, Chemoface: A novel free user-friendly interface for chemometrics, J. Braz. Chem. Soc. 23 (2012), pp. 2003–2010. doi:10.1590/S0103-50532012005000073.
   Web of Science ®Google Scholar
• Molinspiration Cheminformatics free web services, Slovensky Grob, Slovakia. Available at https://www.molinspiration.com
   Google Scholar
• C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Delivery Rev. 46 (2001), pp. 3–26. doi:10.1016/S0169-409X(00)00129-0.
   PubMed Web of Science ®Google Scholar
• M.P. Freitas, MIA-QSAR modelling of anti-HIV-1 activities of some 2-amino-6- arylsulfonylbenzonitriles and their thio and sulfinyl congeners, Org. Biomol. Chem. 4 (2006), pp. 1154–1159. doi:10.1039/b516396j.
   PubMed Web of Science ®Google Scholar